Published in J Virol on August 12, 2015
Characterization of Intra-Type Variants of Oncogenic Human Papillomaviruses by Next-Generation Deep Sequencing of the E6/E7 Region. Viruses (2016) 0.82
Unique LCR variations among lineages of HPV16, 18 and 45 isolates from women with normal cervical cytology in Ghana. Virol J (2017) 0.75
Genotype Distribution of Human Papillomavirus among Women with Cervical Cytological Abnormalities or Invasive Squamous Cell Carcinoma in a High-Incidence Area of Esophageal Carcinoma in China. Biomed Res Int (2016) 0.75
Characterisation of complete high- and low-risk human papillomavirus genomes isolated from cervical specimens in southern Brazil. Mem Inst Oswaldo Cruz (2017) 0.75
Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J (1984) 10.28
GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol (2002) 5.63
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer (2011) 5.43
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol (1987) 5.13
Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J Natl Cancer Inst (2006) 2.67
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82
Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol (2000) 1.78
Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case-control study. Int J Cancer (2003) 1.77
The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res (2012) 1.75
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62
Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol (2004) 1.50
HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer (2009) 1.50
High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer (2007) 1.47
Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res (2003) 1.46
Human papillomavirus genome variants. Virology (2013) 1.45
Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer (2007) 1.45
Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol Biomarkers Prev (2007) 1.43
Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev (2008) 1.29
Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol (2012) 1.26
Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa. Int J Cancer (2011) 1.23
Human papillomavirus infection in women with and without cervical cancer in Nepal. Cancer Causes Control (2009) 1.20
Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland. Eur J Cancer (2008) 1.17
Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan. Br J Cancer (2010) 1.10
Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer (2012) 1.10
Evolution and taxonomic classification of alphapapillomavirus 7 complete genomes: HPV18, HPV39, HPV45, HPV59, HPV68 and HPV70. PLoS One (2013) 1.07
Human papillomaviruses and the specificity of PDZ domain targeting. FEBS J (2012) 1.04
Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions. Virology (2005) 1.03
Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int J Cancer (1995) 1.01
Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women. J Gen Virol (2005) 1.00
Cervical carcinoma in Algiers, Algeria: human papillomavirus and lifestyle risk factors. Int J Cancer (2005) 0.98
Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria. Infect Agent Cancer (2010) 0.96
Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer (2011) 0.95
Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis (2014) 0.95
Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu. Cancer Prev Res (Phila) (2012) 0.92
Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J Med Virol (2007) 0.92
Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol (1997) 0.91
Association between human papillomavirus type 18 variants and histopathology of cervical cancer. J Natl Cancer Inst (1997) 0.89
Human papillomavirus infection in women with and without cervical cancer in Tbilisi, Georgia. Cancer Epidemiol (2011) 0.87
Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences. J Gen Virol (2005) 0.86
Human papillomavirus 33 worldwide genetic variation and associated risk of cervical cancer. Virology (2013) 0.85
Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis (2005) 0.85
Human papillomavirus (HPV) genotype 18 variants in patients with clinical manifestations of HPV related infections in Bilbao, Spain. Virol J (2012) 0.83
Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies. Int J Cancer (2012) 0.83
Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Virol (2014) 0.83
Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain. PLoS One (2014) 0.82
Human papillomavirus type 18 variants: histopathology and E6/E7 polymorphisms in three countries. Int J Cancer (2005) 0.81
New variants of human papillomavirus type 18 identified in central Brazil. Virus Genes (2008) 0.80
Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China. J Med Virol (2014) 0.80
Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. J Obstet Gynaecol Res (2010) 0.79
Elucidating the population histories and transmission dynamics of papillomaviruses using phylogenetic trees. J Mol Evol (1997) 0.79
Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agent Cancer (2014) 0.78
Whole-genome sequence analysis of human papillomavirus type 18 from infected Thai women. Intervirology (2010) 0.78
Variant lineages of human papillomavirus type 18 in Northeast China populations characterized by sequence analysis of E6, E7, and L1 regions. Int J Gynecol Cancer (2012) 0.77
Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer (2006) 3.38
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort. PLoS One (2016) 1.40
World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology (2015) 1.38
Development of a sensitive and specific multiplex PCR method combined with DNA microarray primer extension to detect Betapapillomavirus types. J Clin Microbiol (2007) 1.36
Human papillomavirus type 16 genetic variants: phylogeny and classification based on E6 and LCR. J Virol (2012) 1.26
Risks for persistence and progression by human papillomavirus type 16 variant lineages among a population-based sample of Danish women. Cancer Epidemiol Biomarkers Prev (2011) 1.11
EUROGIN 2008 roadmap on cervical cancer prevention. Int J Cancer (2009) 1.00
Human papillomavirus vaccines and anal carcinoma. Curr Opin HIV AIDS (2009) 0.95
Comprehensive analysis of HPV expression in laryngeal squamous cell carcinoma. J Med Virol (2013) 0.88
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study. Int J Cancer (2015) 0.87
Human Papillomavirus Vaccination of Boys and Extended Catch-up Vaccination: Effects on the Resilience of Programs. J Infect Dis (2015) 0.87
Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era. J Infect Dis (2014) 0.83
Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Virol (2014) 0.83
Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol Biomarkers Prev (2014) 0.83
Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer. Am J Otolaryngol (2013) 0.82
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice. Int J Cancer (2017) 0.82
Type-specific human papillomavirus biological features: validated model-based estimates. PLoS One (2013) 0.82
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017-40: a population-based study. Lancet Oncol (2016) 0.82
VALGENT: A protocol for clinical validation of human papillomavirus assays. J Clin Virol (2015) 0.81
Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer (2017) 0.80
Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya. PLoS One (2014) 0.79
Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer. Int J Cancer (2017) 0.78
Comparison of Two Widely Used Human Papillomavirus Detection and Genotyping Methods, GP5+/6+-Based PCR Followed by Reverse Line Blot Hybridization and Multiplex Type-Specific E7-Based PCR. J Clin Microbiol (2016) 0.78
Prevalence of HPV infection and other risk factors in a Fijian population. Infect Agent Cancer (2014) 0.78
Baseline and lifetime alcohol consumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer (2015) 0.77
Prevalence and concordance of human papillomavirus infection at multiple anatomic sites among HIV-infected women from Chennai, India. Int J STD AIDS (2015) 0.77
HPV16 variants in squamous intraepithelial lesions in human immunodeficiency virus-negative and -positive Brazilian women. Viral Immunol (2006) 0.76
Hepatitis C Virus Seroprevalence in Mongolian Women Assessed by a Novel Multiplex Antibody Detection Assay. Cancer Epidemiol Biomarkers Prev (2015) 0.76
Embryonic cells in the squamous-columnar junction of the cervix: scope for prophylactic ablation? Int J Cancer (2014) 0.76
Infection with hepatitis viruses, FIB-4 index and risk of hepatocellular carcinoma in southern Italy: a population-based cohort study. Infect Agent Cancer (2016) 0.75
Carcinogenicity of Human Papillomavirus (HPV) Types in HIV-Positive Women: A Meta-Analysis From HPV Infection to Cervical Cancer. Clin Infect Dis (2017) 0.75
Low frequency of cigarette smoking and the risk of head and neck cancer in the INHANCE consortium pooled analysis. Int J Epidemiol (2015) 0.75
Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study. J Infect Dis (2017) 0.75
β- and γ-Human Papillomavirus Types and Smoking in Head and Neck Cancer. JAMA Oncol (2016) 0.75
Consumption of Fish Is Not Associated with Risk of Differentiated Thyroid Carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J Nutr (2017) 0.75
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. Microbiol Spectr (2022) 0.75
Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan. Oncotarget (2017) 0.75
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget (2017) 0.75
HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget (2017) 0.75
Prospects for primary prevention of cervical cancer in developing countries. Salud Publica Mex (2003) 0.75
Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study. PLoS One (2017) 0.75
Cervical screening: toward an equal risk/equal management approach, irrespective of HIV status. AIDS (2017) 0.75
Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study. PLoS One (2017) 0.75